Top Markets
#1 MowCat MowCat +777.32%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.82%
#3 SIXSEVEN SIXSEVEN +49.97%
#4 MarsCoin MarsCoin +38.87%
#5 Akedo Akedo +38.69%
#6 Magma Finance Magma Finance +37.90%
#7 Cortex Cortex +26.19%
#8 DeXe DeXe +23.56%
#9 OpenEden OpenEden +13.99%
#10 Pons Pons +12.53%
Coin of the day
MowCat MowCat
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Rang in aandelen #8284
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Aandeelprijs
$24.37
Marktkapitalisatie
$1.30B
Verandering (1 dag)
-7.16%
Verandering (1 jaar)
-
Land
US
Handel Seaport Therapeutics, Inc. Common Stock (SPTX)

Categorie

Healthcare
Winst voor Seaport Therapeutics, Inc. Common Stock (SPTX)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van Seaport Therapeutics, Inc. Common Stock bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Seaport Therapeutics, Inc. Common Stock van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH